Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-0910
Dr. Arun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 1994 - 1997
Istanbul University FomClass of 1989
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
MS State Medical License 2023 - 2027
OK State Medical License 2020 - 2027
TN State Medical License 2023 - 2027
TX State Medical License 1998 - 2027
GA State Medical License 2023 - 2026
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- US Top 27 Breast Oncologist Forbes, 2017
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013, 2015
- America's Top Doctors Castle Connolly, 2009-2014
Clinical Trials
- Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer Start of enrollment: 2005 Sep 01
- Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer Start of enrollment: 2003 Oct 03
- A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer Start of enrollment: 2008 Mar 01
Publications & Presentations
PubMed
- Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.Katherine D Crew, Garnet L Anderson, Kathryn B Arnold, Sam Dzingle, Alissa Michel
Journal of the National Cancer Institute. 2026-07-02 - Clinical Characteristics and Cancer Histories Among Breast Cancer Patients With Li-Fraumeni Syndrome From a Single Institution.Ashley H Woodson, Aydah Al-Awadhi, Jessica Corredor, Jacynda Casey, Hiam M Abdel-Salam
Clinical Breast Cancer. 2026-06-01 - Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial.Kamaria L Lee, Clinton Yam, Li Zhao, Roland L Bassett, Xingzhi Song
Breast Cancer Research and Treatment. 2026-06-01
Journal Articles
- Functional Mechanisms Underlying Pleiotropic Risk Alleles at the 19p13.1 Breast–Ovarian Cancer Susceptibility LocusSusan M Domchek, Beth Y Karlan, Katherine L Nathanson, Kenneth Offit, Banu K Arun, Andrew Berchuck, Patricia A Ganz, Douglas A Levine, Nature
Press Mentions
NCCN Issues Updated Guidance on Genetic Testing for Several CancersNovember 25th, 2024- MD Anderson Research Highlights for August 25, 2021August 25th, 2021
- Clinical Challenge: BRCA-Mutant Triple-Negative Breast CancerJune 8th, 2021
Grant Support
- Biomarker Modulation/Cox-2 Inhibitor/Breast CancerNational Cancer Institute2002–2003
- An Exploratory Study To Identify Potential Surrogate ENDDivision Of Cancer Prevention And Control1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
